Key result
Nonischemic LV scar in asymptomatic athletes links to 5% major arrhythmia rate, exclusively with family history.
Why the study?
Isolated nonischemic left ventricular scar (NILVS) in asymptomatic athletes is increasingly detected but its clinical significance and arrhythmic risk remain unclear.
Observational (n=40)
Asymptomatic athletes with isolated nonischemic left ventricular scar may be at risk for major arrhythmic events, highlighting the need for careful risk stratification including family history.
NILVS may confer arrhythmic risk in asymptomatic athletes; leaves open refined predictors beyond family history for prospective validation.
BACKGROUND: Isolated nonischemic left ventricular scar (NILVS), identified by cardiac magnetic resonance, is an increasing finding in athletes and may be the substrate for life-threatening arrhythmias. Clinical significance in asymptomatic athletes is yet to be investigated. OBJECTIVES: This study sought to describe the clinico-genetic profile and follow-up of asymptomatic athletes diagnosed with NILVS through preparticipation screening. METHODS: We evaluated 40 athletes (90% males, 44 [range:33-52] years) including 9 elites, with isolated NILVS involving at least 2 segments, no previous major arrhythmic events, with available genetic testing and >1 year of follow-up. Data regarding electrocardiography, echocardiography, 24-hour Holter, exercise testing, and genetic analysis were collected. Follow-up assessed therapy, sport participation, and outcome. RESULTS: Electrocardiogram abnormalities were present in 48%, and all showed premature ventricular beats at exercise testing, mostly with right bundle branch/superior axis morphology. Left ventricular ejection fraction was normal or mildly reduced. Genetic testing or family screening was positive in 9 (23%). Athletes without familial/genetic background were older and declared higher cumulative years of sports activity. Over a median follow-up time of 23 months, 84% continued noncompetitive sport, mostly (73%) on beta-blocker therapy. Two major arrhythmic events occurred (resuscitated cardiac arrest and sustained ventricular tachycardia), both in athletes with a positive family history for NILVS, but negative genetic testing, and both during noncompetitive exercise. CONCLUSIONS: NILVS in asymptomatic athletes may carry arrhythmic risk even in the absence of previous symptoms or left ventricular dysfunction. Athletes with NILVS and no gene mutations/family history are older and with a higher past exercise volume.
No takes yet. Share an insight, caveat, or question.
Zorzi et al. (2026) conducted an observational in Isolated nonischemic left ventricular scar (n=40). Isolated nonischemic left ventricular scar (NILVS) was evaluated on Major arrhythmic events (resuscitated cardiac arrest and sustained ventricular tachycardia). Isolated nonischemic left ventricular scar in asymptomatic athletes was associated with a 5% rate of major arrhythmic events over 23 months, occurring exclusively in those with a family history.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: